Log In
Print
BCIQ
Print
Print this Print this
 

Talimogene laherparepvec (formerly OncoVEX GM-CSF)

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionModified herpes simplex virus type 1 (HSV-1) encoding GM-CSF
Molecular Target
Mechanism of ActionOncolytic virus
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase III
Standard IndicationMelanoma
Indication DetailsTreat melanoma; Treat metastatic melanoma
Regulatory Designation

U.S. - Special Protocol Assessment (Treat metastatic melanoma)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today